In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker

Biochemical and Biophysical Research Communications

Volumn 330, Issue 2, 2005, Pages 415-422

  Sonta, Toshiyo ^a   Inoguchi, Toyoshi ^a   Matsumoto, Shingo ^b   Yasukawa, Keiji ^b   Inuo, Mieko ^a   Tsubouchi, Hirotaka ^a   Sonoda, Noriyuki ^a   Kobayashi, Kunihisa ^a   Utsumi, Hideo ^b   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Angiotensin II type 1 receptor blocker; Diabetes; Nephropathy; Oxidative stress

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; OLMESARTAN; STREPTOZOCIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTRON SPIN RESONANCE; IMAGING; IN VIVO STUDY; KIDNEY; KIDNEY DISEASE; MALE; MOLECULAR PROBE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; TECHNIQUE;

EID: 20144376707     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.02.174     Document Type: Article

References (34)

1. T.H. Hostetter, H.G. Rennke, and B.M. Brenner The case for intrarenal hypertension in the initiation and progression of diabetic and glomerulonephritis Am. J. Med. 72 1982 375 380
2. M. Brownlee, A. Cerami, and H. Vlassara Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N. Engl. J. Med. 318 1988 1315 1321
3. P.A. Craven, and F.R. DeRubertis Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose J. Clin. Invest. 83 1989 1667 1675
4. T. Inoguchi, R. Battan, E. Handler, J.R. Sportsman, W. Heath, and G.L. King Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation Proc. Natl. Acad. Sci. USA 89 1992 11059 11063
5. D. Koya, and G.L. King Protein kinase C activation and the development of diabetic complications Diabetes 47 1998 859 866
6. D.A. Greene, S.A. Lattimer, and A.A. Sima Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications N. Engl. J. Med. 316 1987 599 606
7. L.W. Oberley Free radicals and diabetes Free Radic. Biol. Med. 5 1988 113 124
8. J.W. Baynes Role of oxidative stress in development of complications in diabetes Diabetes 40 1991 405 412
9. T. Nishikawa, D. Edelstein, X.L. Du, S. Yamagishi, T. Matsumura, Y. Kaneda, M.A. Yorek, D. Beebe, P.J. Oates, H.P. Hammes, I. Giardino, and M. Brownlee Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage Nature 404 2000 787 790
10. T. Inoguchi, P. Li, F. Umeda, H.Y. Yu, M. Kakimoto, M. Imamura, T. Aoki, T. Etoh, T. Hashimoto, M. Naruse, H. Sano, H. Utsumi, and H. Nawata High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells Diabetes 49 2000 1939 1945
11. P. Dandona, K. Thusu, S. Cook, B. Snyde, J. Makowski, D. Armstrong, and T. Nicotera Oxidative damage to DNA in diabetes mellitus Lancet 348 1996 444 445
12. H. Ha, C. Kim, Y. Son, M.H. Chung, and K.H. Kim DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria Free Radic. Biol. Med. 16 1994 271 274
13. T. Kakimoto, T. Inoguchi, T. Sonta, H.Y. Yu, M. Imamura, T. Etoh, T. Hashimoto, and H. Nawata Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats Diabetes 51 2002 1588 1595
14. H. Utsumi, E. Muto, S. Masuda, and A. Hamada In vivo ESR measurement of free radicals in whole mice Biochem. Biophys. Res. Commun. 172 1990 1342 1348
15. H.M. Swartz Principles of the metabolism of nitroxides and their implications for spin trapping Free Radic. Res. Commun. 9 1990 399 405
16. T. Sano, F. Umeda, T. Hashimoto, H. Nawata, and H. Utsumi Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes Diabetologia 41 1998 1355 1360
17. T. Sonta, T. Inoguchi, H. Tsubouchi, N. Sekiguchi, K. Kobayashi, S. Matsumoto, H. Utsumi, and H. Nawata Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity Free Radic. Biol. Med. 37 2004 115 123
18. H. Togashi, H. Shinzawa, T. Matsuo, Y. Takeda, T. Takahashi, M. Aoyama, K. Oikawa, and H. Kamada Analysis of hepatic oxidative stress status by electron spin resonance spectroscopy and imaging Free Radic. Biol. Med. 28 2000 846 853
19. P. Kuppusamy, H. Li, G. Hangovan, A.J. Cardounel, J.L. Zweer, K. Yamada, M.C. Krishan, and J.B. Mitchell Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels Cancer Res. 62 2002 307 312
20. H. Utsumi, and K. Yamada In vivo electron spin resonance-computed tomography/nitroxyl probe technique for non-invasive analysis of oxidative injuries Arch. Biochem. Biophys. 416 2003 1 8
21. H. Sano, M. Naruse, K. Matsumoto, T. Oi, and H. Utsumi A new nitroxyl-probe with high retention in the brain and its application for brain imaging Free Radic. Biol. Med. 28 2000 959 969
22. .NO Biophys. J. 79 2000 3341 3349
23. T. Etoh, T. Inoguchi, M. Kakimoto, N. Sonoda, K. Kobayashi, J. Kuroda, H. Sumimoto, and H. Nawata Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibility by interventive insulin treatment Diabetologia 46 2003 1428 1437
24. A. Hirayama, S. Nagase, A. Ueda, T. Oteki, K. Takada, M. Obara, M. Inoue, K. Yoh, K. Hirayama, and A. Koyama In vivo imaging of oxidative stress in ischemia-reperfusion renal injury using electron paramagnetic resonance Am. J. Physiol. Renal Physiol. 288 2005 F597 F603
25. M.E. Copper, F. Bonnet, M. Oldfield, and K. Jandeleit-Dahm Mechanisms of diabetic vasculopathy: an overview Am. J. Hypertens. 14 2001 475 486
26. D.J. Leehey, A.K. Singh, N. Alavi, and R. Singh Role of angiotensin II in diabetic nephropathy Kidney Int. Suppl. 77 2000 s93 s98
27. X.R. Huang, W.Y. Chen, L.D. Truong, and H.Y. Lan Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease J. Am. Soc. Nephrol. 14 2003 1738 1747
28. E.J. Lewis, L.G. Hunsicker, R.P. Bain, and R.D. Rohde The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group N. Engl. J. Med. 329 1993 1456 1462
29. E.J. Lewis, L.G. Hunsicker, W.R. Clarke, T. Berl, M.A. Pohl, J.B. Lewis, E. Ritz, R.C. Atkins, R. Rohde, and I. Raz Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N. Engl. J. Med. 3458 2001 851 860
30. H.H. Parving, H. Lehnert, J. Brochner-Mortensen, R. Gomis, S. Andersen, and P. Arner The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N. Engl. J. Med. 345 2001 870 878
31. B.M. Brenner, M.E. Cooper, D.K. de Zeeuw, F.M. William, E. William, H.H. Parving, G. Remuzzi, S.M. Snapinn, Z. Zhang, and S. Shahinfar Effects of losartam on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N. Engl. J. Med. 345 2001 861 869
32. E.A. Jaimes, J.M. Galceran, and L. Raij Angiotensin II induces superoxide anion production by mesangial cells Kidney Int. 54 1998 775 784
33. K.K. Griendling, C.A. Minieri, J.D. Ollerenshaw, and R.W. Alexande Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells Circ. Res. 74 1994 1141 1148
34. U. Rueckschloss, M.T. Quinn, J. Holtz, and H. Morawietz Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease Arterioscler. Thromb. Vasc. Biol. 22 2002 1845 1851